8-K

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549



                                    FORM 8-K

                                 CURRENT REPORT


                       Pursuant to Section 13 or 15(d) of
                      the Securities and Exchange Act 1934


Date of Report (Date of earliest event reported):    February 28, 2006

                            INTEGRAMED AMERICA, INC.
- -------------------------------------------------------------------------------
               (Exact name of registrant as specified in charter)

                                    Delaware
- -------------------------------------------------------------------------------
                 (State of other jurisdiction of incorporation)

                 0-20260                               6-1150326
- -------------------------------------------------------------------------------
           (Commission File Numbers)      (IRS Employer Identification No.)

 Two Manhattanville Road, Purchase, NY                    10577
- -------------------------------------------------------------------------------
(Address of principal executive offices)               (Zip Code)

Registrant's telephone no. including area code: (914) 253-8000
                                                --------------

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

       Written  communication  pursuant to Rule 425 under the Securities Act (17
___    CFR 230.425)

       Soliciting  material  pursuant to Rule 14a-12  under the Exchange Act (17
___    CFR 240.14a-12)

       Pre-commencement  communication  pursuant  to  Rule  14d-2(b)  under  the
___    Exchange Act (17 CFR 240.14d-2(b)

       Pre-commencement  communication  pursuant  to  Rule  13e-4(c)  under  the
___    Exchange Act (17 CFR 240.13e-4(c))







ITEM 7.01    Regulation FD Disclosure

              Registrant's  Press  Release  dated  February 28, 2006 attached as
Exhibit 99.102 hereto is furnished pursuant to Regulation FD; it is not filed.


ITEM 9.01.  Financial Statements, Pro Forma Financial Information and Exhibits

         (c)  Exhibits

              Exhibit No.   Description of Exhibit
              -----------   ----------------------
              99.102        Registrant's Press Release dated February 28, 2006







                                                          SIGNATURES


         Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


                                             INTEGRAMED AMERICA, INC.
                                             (Registrant)



Date:    February 28, 2006               By: /s/John W. Hlywak, Jr.
                                            -----------------------------------
                                            John W. Hlywak, Jr.
                                            Sr. Vice President and
                                            Chief Financial Officer
                                            (Principal Financial and
                                            Accounting Officer)

EX-99

[GRAPHIC OMITTED][GRAPHIC OMITTED]

 John W. Hlywak, Jr. (Investors)              Scott Soifer (Media & Physicians)
 Senior Vice President                        Vice President Marketing
 & CFO                                        & Development
IntegraMed America, Inc.                      IntegraMed America, Inc.
 (914) 251-4143                                (914) 251-4186
 email:  jhlywak@integramed.com                email:scott.soifer@integramed.com
         ----------------------                      ---------------------------
 Web Address:  http://www.integramed.com
                   -------------------------


         IntegraMed(TM) Network Practice Grows Through New Relationship

             Harvard Vanguard Medical Associates signs Letter of Intent with
IntegraMed network member RSC of New England

PURCHASE, NEW YORK, February 28, 2006 - IntegraMed America, Inc. (Nasdaq: INMD),
the largest fertility-services company in the United States, today announced
that Harvard Vanguard Medical Associates, a Massachusetts multi-specialty
physician practice, has signed a letter of intent providing for the Reproductive
Science Center of New England (RSC) to be its preferred provider for Assisted
Reproductive Technology (ART) healthcare services, which includes in vitro
fertilization.

The agreement is scheduled to take effect April 1. Patients of Harvard
Vanguard's reproductive endocrinologists - physician sub-specialists who provide
IVF and other treatments within the medical field of assisted reproductive
technology - will continue seeing Harvard Vanguard physicians for routine visits
at the four locations of the Harvard Vanguard Center for Fertility and
Reproductive Health. But IVF lab procedures and surgeries (egg retrievals from
female patients) now will be performed at RSC's clinic and world-renowned
embryology lab in Lexington, Massachusetts. RSC will have access to the four
Harvard Vanguard treatment locations for routine cycle monitoring of their
patients.

The agreement is likely to increase by about 30 percent the number of IVF cycles
or treatments under RSC's care, to more than 2,000 each year, when fully
implemented, making RSC one of the two largest infertility practices in New
England.

                                    - more -


                                 HVMA partners with RSC of New England, page 2/2

Patricia M. McShane, M.D., RSC medical director stated that "We're honored to
have the opportunity to work with one of the finest groups of physicians in the
country and to help their patients reach their goals of parenthood." She further
noted that "the leadership of both Harvard Vanguard and IntegraMed in electronic
medical records will make working together very straightforward and streamlined.
RSC's usage of IntegraMed's ARTworks(R) electronic medical record was a key
factor as we explored how we could coordinate care with Harvard Vanguard."

"IntegraMed will focus its resources on making the relatively short transition
period as seamless as possible for the benefit of all, particularly patients,"
said Jay Higham, IntegraMed's president and CEO. "We see this as another example
of how IntegraMed is capable of utilizing its resources to help create
innovative strategic alliances to the benefit of all participants. For us,
adding Harvard Vanguard IVF volume to our network is the equivalent of adding
the IVF volume of another large fertility center. When put to the test, we can
marshal our resources, which we believe are unmatched in this field, to help our
fertility center partners improve their performance and achieve their goals of
superior care, more patients, greater efficiency and long term growth."

                                       ###

                         About IntegraMed America, Inc.
IntegraMed America, Inc. provides business services to a national network of 26
fertility centers in 78 locations across the United States; distributes
pharmaceutical products and treatment financing programs directly to consumers;
and operates the Web site http://www.integramed.com, a leading fertility portal.
The IntegraMed network includes nearly 150 physicians and Ph.D. scientists.
Network membership is limited to one practice per metropolitan area, yet one of
every five procedures in the U.S. is performed in an IntegraMed practice.
IntegraMed provides more services to both consumers and medical providers in the
fertility field than any other consortium.

===============================================================================

Statements contained in this press release that are not based on historical
fact, including statements concerning future results, performance, expectations
and expansion of IntegraMed are forward-looking statements that may involve a
number of risks and uncertainties. Actual results may differ materially from the
statements made as a result of various factors, including, but not limited to,
the risks associated with IntegraMed's ability to finance future growth; the
loss of significant business services contract(s); profitability at Reproductive
Science Centers serviced by IntegraMed; changes in insurance coverage,
government laws and regulations regarding health care or managed care
contracting; and other risks, including those identified in the company's most
recent Form 10-K and in other documents filed by IntegraMed with the U.S.
Securities and Exchange Commission. All information in this press release is as
of February 28, 2006 and IntegraMed undertakes no duty to update this
information.